Scotiabank (TSX:BNS) analyst Greg Harrison updated the price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), a ...

Scotiabank (TSX:BNS) increased its price target for INmune Bio Inc. (NASDAQ:INMB) shares to $23.00, up from the previous target of $22.00, while maintaining a Sector Outperform rating. The stock, ...

In a report released today, Andres Coello from Scotiabank maintained a Buy rating on AST SpaceMobile (ASTS – Research Report), with a price ...

In a report released today, Nick Altmann from Scotiabank maintained a Hold rating on JFrog (FROG – Research Report), with a price target of ...

ECB President Lagarde told EU lawmakers yesterday that inflationary pressures were easing and the central bank was on target ...

"BoE rate setter Mann justified her sudden switch from rate hawk to dove with the need to 'cut through the noise', suggesting ...

The Giller Prize has parted ways with its lead sponsor Scotiabank more than a year after members of the literary community ...

While confirming an ongoing fraud attempt affecting debit card holders, Scotiabank is insisting that the issue is not ...

Rogers Sugar (TSE:RSI – Free Report) had its price target cut by Scotiabank from C$6.25 to C$6.00 in a research report report published on Friday,BayStreet.CA reports. They currently have an equal ...

Qualys (NASDAQ:QLYS – Free Report) had its target price reduced by Scotiabank from $150.00 to $140.00 in a report published on Friday morning,Benzinga reports. They currently have a sector perform ...

The Giller Foundation ended its relationship with its main sponsor Scotiabank on Monday, following a prolonged pressure ...

In a statement shared with the Star, the foundation behind the Giller Prize said it plans to "explore new opportunities and ...